Vifor Pharma reported changes to its management. Dr. Klaus Henning Jensen will join the company as Chief Medical Officer and Member of the Executive Committee in January 2020. Dario Eklund, Chief Commercial Officer and member of the Executive Committee will leave the company at the end of September. Dr. Jensen joins Vifor Pharma from Sanofi, where he has most recently been Global Therapeutic Area Head, responsible for diabetes, cardiovascular and metabolism development. Vifor Pharma also announced the departure of Dario Eklund. Dario Eklund joined Vifor Pharma in 2014 as Head of Global Business Operations, before becoming Chief Commercial Officer in 2017. He has decided to pursue opportunities outside of Vifor Pharma, and will leave the organisation by the end of September.